The UFIM (Ultraprocessed Foods In Breast Milk) Project
UFIM
ASSESSMENT OF THE PRESENCE OF DERIVATIVES OF ULTRA-PROCESSED FOODS IN BREAST MILK- The UFIM (Ultraprocessed Foods In Breast Milk) Project
1 other identifier
observational
300
1 country
1
Brief Summary
In last decades, a change in dietary habits has been observed in industrialized countries characterized by a drastic increase in the consumption of ultra-processed foods (UPF, Ultra-Processed Foods). As defined by the NOVA classification, UPFs are industrial formulations of food substances added with colourings, flavourings, emulsifiers, thickeners and other additives. Among the main compounds of UPFs are the advanced glycation end-products (AGEs). Increasing evidence suggests an association between dietary exposure to AGEs and the development of chronic non-communicable diseases, such as obesity and allergies, in the general population, through increased oxidative stress and inflammation. Preliminary evidence suggests that a maternal diet rich in AGEs during pregnancy and lactation could negatively influence the composition of breast milk and have a negative impact on the infants health. However, data regarding the presence of derivatives of UPFs in breast milk are not available. The UFIM (Ultraprocessed Foods In Breast Milk) study aims at evaluate the presence of UPFs-derivatives compounds in breast milk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2023
CompletedFirst Submitted
Initial submission to the registry
May 26, 2023
CompletedFirst Posted
Study publicly available on registry
June 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 23, 2026
June 4, 2025
June 1, 2025
3 years
May 26, 2023
June 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the presence of the major UPFs-derived compounds AGEs in breast milk
Through the liquid chromatography with triple quadrupole mass spectrometric detection techniques (LC-MS/MS) will be assessed the quantity of AGEs in breast milk.
36 months
Secondary Outcomes (3)
Dietary intake of UPF in lactating women
36 months
Dietary intake of AGEs in lactating women
36 months
Skin AGEs accumulation levels in lactating women
36 months
Study Arms (1)
Lactacting women who are breastfeeding full-term infants
Caucasian women aged between 18 and 35 who are breastfeeding full-term infants observed at Pediatrics Section of Department of Translational Medical Sciences (University of Naples Federico II)
Eligibility Criteria
Caucasian women aged between 18 and 35 who are breastfeeding full-term infants observed at Pediatrics Section of Department of Translational Medical Sciences (University of Naples Federico II)
You may qualify if:
- Caucasian women who are breastfeeding full-term infants
You may not qualify if:
- Non-Caucasian ethnicity;
- Age \<18 and \>35 years;
- Mothers of preterm children;
- Non-exclusive breastfeeding;
- Mothers suffering from chronic, malignancies, immunodeficiencies, chronic infections, autoimmune, inflammatory bowel disease, celiac disease, genetic-metabolic diseases, cystic fibrosis and other chronic lung diseases, cardiovascular / respiratory / intestinal malformations, neuropsychiatric disorders and pathologies neurological, vegetarian and vegan diet;
- Mothers with tattoos, scars, moles or skin lesions on both forearms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Traslational Medical Science - University of Naples Federico II
Naples, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, Doctor of Philosophy, Full Professor
Study Record Dates
First Submitted
May 26, 2023
First Posted
June 5, 2023
Study Start
May 23, 2023
Primary Completion (Estimated)
May 23, 2026
Study Completion (Estimated)
May 23, 2026
Last Updated
June 4, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share